Stroke without cerebral arteriopathy in sickle cell disease children: causes and treatment.


Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
14 Mar 2024
Historique:
received: 22 06 2023
medline: 18 3 2024
pubmed: 18 3 2024
entrez: 18 3 2024
Statut: aheadofprint

Résumé

Cerebral arteriopathy (CA) in children with sickle cell disease (SCD) is classically described as chronic stenosis of arteries in the anterior brain circulation, leading to ischemic stroke. Some studies have however reported strokes in children with SCD but without CA. In order to better understand the etiology and risk factors of these strokes, we retrospectively analyzed ischemic strokes occurring in a large cohort of children over a 13 year-period. Between 2007 and 2020, 25/1500 children with SCD had an ischemic stroke in our center. Among them, 13 (52%) had CA, described as anatomical arterial stenosis, while 12 (48%) did not. Patients with stroke without CA were older than patients with stroke attributed to SCD-CA (9.0 years old vs 3.6 years old, p=0.008), and had more frequently a SC genotype (25% vs 0% respectively). Their stroke involved posterior circulation more frequently, with cerebellar involvement in 42%. Retained stroke etiologies in patients without typical SCD-related CA were reversible cerebral vasoconstriction syndrome, cerebral fat embolism, arterial thrombosis or thromboembolism, hyperviscosity, vasculitis in a context of infectious meningoencephalitis, and severe hemodynamic failure. No recurrence was observed in the 24 months following stroke, even though 67% of the patients were no longer receiving exchange transfusions in this group. In conclusion, in a cohort of pediatric SCD patients with efficient stroke screening strategy, half of occurring ischemic strokes were related to causes other than CA. They affected a different population of SCD children and systematic long-term transfusion programs may not be necessary in these cases.

Identifiants

pubmed: 38497171
doi: 10.3324/haematol.2023.283773
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Sarah Liane Linguet (SL)

Referral Center for Sickle Cell Disease, Hematology Unit, Robert Debre Hospital, AP-HP, Paris.

Suzanne Verlhac (S)

INSERM UMR_S1134 BIGR, Paris.

Florence Missud (F)

Referral Center for Sickle Cell Disease, Hematology Unit, Robert Debre Hospital, AP-HP, Paris.

Laurent Holvoet-Vermaut (L)

Referral Center for Sickle Cell Disease, Hematology Unit, Robert Debre Hospital, AP-HP, Paris.

Valentine Brousse (V)

Referral Center for Sickle Cell Disease, Hematology Unit, Robert Debre Hospital, AP-HP, Paris, France; INSERM UMR_S1134 BIGR, Paris.

Ghislaine Ithier (G)

Referral Center for Sickle Cell Disease, Hematology Unit, Robert Debre Hospital, AP-HP, Paris.

Alexandra Ntorkou (A)

Radiology Unit, Robert Debre Hospital, AP-HP, Paris.

Emmanuelle Lesprit (E)

Etablissement Français du Sang.

Malika Benkerrou (M)

Referral Center for Sickle Cell Disease, Hematology Unit, Robert Debre Hospital, AP-HP, Paris, France; INSERM UMR_S1123 ECEVE, Paris.

Manoëlle Kossorotoff (M)

French Center for Pediatric Stroke, Pediatric Neurology Department, University Hospital Necker-Enfants Malades, AP-HP, Paris, France; and INSERM U1266, Paris.

Berengere Koehl (B)

Referral Center for Sickle Cell Disease, Hematology Unit, Robert Debre Hospital, AP-HP, Paris, France; INSERM UMR_S1134 BIGR, Paris, France; Université de Paris Cité, Paris. berengere.koehl@aphp.fr.

Classifications MeSH